HCC - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Tecentriq and Avastin improves survival in Phase III cancer trial

Hepatocellular carcinoma is an aggressive cancer estimated to affect more than 50,000 people per year. Credit: humpath.com.